1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394–424.
2. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009; 59:366–78.
3. Ghoncheh M, Mohammadian M, Mohammadian-Hafshejani A, Salehiniya H. The incidence and mortality of colorectal cancer and its relationship with the human development index in Asia. Ann Glob Health. 2016; 82:726–37.
4. Shaukat A, Dostal A, Menk J, Church TR. BMI is a risk factor for colorectal cancer mortality. Dig Dis Sci. 2017; 62:2511–7.
5. Grontved A, Hu FB. Television viewing and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a meta-analysis. JAMA. 2011; 305:2448–55.
6. Kim Y, Wilkens LR, Park SY, Goodman MT, Monroe KR, Kolonel LN. Association between various sedentary behaviours and all-cause, cardiovascular disease and cancer mortality: the Multiethnic Cohort Study. Int J Epidemiol. 2013; 42:1040–56.
7. Cao J, Eshak ES, Liu K, Muraki I, Cui R, Iso H, et al. Television viewing time and breast cancer incidence for Japanese premenopausal and postmenopausal women: the JACC study. Cancer Res Treat. 2019; 51:1509–17.
8. Bauman A, Ainsworth BE, Sallis JF, Hagstromer M, Craig CL, Bull FC, et al. The descriptive epidemiology of sitting: a 20-country comparison using the International Physical Activity Questionnaire (IPAQ). Am J Prev Med. 2011; 41:228–35.
9. Sugiyama T, Healy GN, Dunstan DW, Salmon J, Owen N. Is television viewing time a marker of a broader pattern of sedentary behavior? Ann Behav Med. 2008; 35:245–50.
10. Nguyen LH, Liu PH, Zheng X, Keum N, Zong X, Li X, et al. Sedentary behaviors, TV viewing time, and risk of young-onset colorectal cancer. JNCI Cancer Spectr. 2018; 2:pky073.
11. Keum N, Cao Y, Oh H, Smith-Warner SA, Orav J, Wu K, et al. Sedentary behaviors and light-intensity activities in relation to colorectal cancer risk. Int J Cancer. 2016; 138:2109–17.
12. Tamakoshi A, Ozasa K, Fujino Y, Suzuki K, Sakata K, Mori M, et al. Cohort profile of the Japan Collaborative Cohort Study at final follow-up. J Epidemiol. 2013; 23:227–32.
13. Tan C, Mori M, Adachi Y, Wakai K, Suzuki S, Suzuki K, et al. Diabetes mellitus and risk of colorectal cancer mortality in Japan: the Japan Collaborative Cohort Study. Asian Pac J Cancer Prev. 2016; 17:4681–8.
14. Jones M, Fowler R. Immortal time bias in observational studies of time-to-event outcomes. J Crit Care. 2016; 36:195–9.
15. Morris JS, Bradbury KE, Cross AJ, Gunter MJ, Murphy N. Physical activity, sedentary behaviour and colorectal cancer risk in the UK Biobank. Br J Cancer. 2018; 118:920–9.
16. Ma P, Yao Y, Sun W, Dai S, Zhou C. Daily sedentary time and its association with risk for colorectal cancer in adults: a dose-response meta-analysis of prospective cohort studies. Medicine (Baltimore). 2017; 96:e7049.
17. Cao Y, Meyerhardt JA, Chan AT, Wu K, Fuchs CS, Giovannucci EL. Television watching and colorectal cancer survival in men. Cancer Causes Control. 2015; 26:1467–76.
18. Campbell PT, Patel AV, Newton CC, Jacobs EJ, Gapstur SM. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol. 2013; 31:876–85.
19. Baran B, Mert Ozupek N, Yerli Tetik N, Acar E, Bekcioglu O, Baskin Y. Difference between left-sided and right-sided colorectal cancer: a focused review of literature. Gastroenterology Res. 2018; 11:264–73.
20. Aran V, Victorino AP, Thuler LC, Ferreira CG. Colorectal cancer: epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer. 2016; 15:195–203.
22. Henson J, Yates T, Edwardson CL, Khunti K, Talbot D, Gray LJ, et al. Sedentary time and markers of chronic low-grade inflammation in a high risk population. PLoS One. 2013; 8:e78350.
23. Cooney RV, Chai W, Franke AA, Wilkens LR, Kolonel LN, Le Marchand L. C-reactive protein, lipid-soluble micronutrients, and survival in colorectal cancer patients. Cancer Epidemiol Biomarkers Prev. 2013; 22:1278–88.
24. McTiernan A. Obesity and cancer: the risks, science, and potential management strategies. Oncology (Williston Park). 2005; 19:871–81.
25. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007; 86:s836–42.
26. Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G. Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum. 2013; 56:1304–19.
27. Richardson LC, Pollack LA. Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol. 2005; 2:48–53.
28. Fuchs CS, Goldberg RM, Sargent DJ, Meyerhardt JA, Wolpin BM, Green EM, et al. Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741. Clin Cancer Res. 2008; 14:8263–9.
29. Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, et al. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol. 2009; 27:176–85.
30. Sisson SB, Shay CM, Broyles ST, Leyva M. Television-viewing time and dietary quality among U.S. children and adults. Am J Prev Med. 2012; 43:196–200.
31. Young GP. Colorectal disorders: a dietary management perspective. Asia Pac J Clin Nutr. 2000; 9(Suppl 1):S76–82.
32. Clark BK, Sugiyama T, Healy GN, Salmon J, Dunstan DW, Owen N. Validity and reliability of measures of television viewing time and other non-occupational sedentary behaviour of adults: a review. Obes Rev. 2009; 10:7–16.
33. Buccafusca G, Proserpio I, Tralongo AC, Rametta Giuliano S, Tralongo P. Early colorectal cancer: diagnosis, treatment and survivorship care. Crit Rev Oncol Hematol. 2019; 136:20–30.